76 related articles for article (PubMed ID: 1767729)
1. Single sc administration of insulin-like growth factor I (IGF-I) in normal men.
Hizuka N; Takano K; Asakawa K; Fukuda I; Sukegawa I; Shizume K; Demura H
Adv Exp Med Biol; 1991; 293():105-12. PubMed ID: 1767729
[TBL] [Abstract][Full Text] [Related]
2. Effects of sc administration of recombinant human insulin-like growth factor I (IGF-I) on normal human subjects.
Takano K; Hizuka N; Asakawa K; Sukegawa I; Shizume K; Demura H
Endocrinol Jpn; 1990 Apr; 37(2):309-17. PubMed ID: 2226347
[TBL] [Abstract][Full Text] [Related]
3. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
Clemmons DR; Smith-Banks A; Underwood LE
J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
[TBL] [Abstract][Full Text] [Related]
4. Repeated sc administration of recombinant human insulin-like growth factor I (IGF-I) to human subjects for 7 days.
Takano K; Hizuka N; Shizume K; Asakawa K; Fukuda I; Demura H
Growth Regul; 1991 Mar; 1(1):23-8. PubMed ID: 1842557
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion.
Harel Z; Tannenbaum GS
Endocrinology; 1992 Aug; 131(2):758-64. PubMed ID: 1639021
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
8. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
Bach MA; Chin E; Bondy CA
J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
[TBL] [Abstract][Full Text] [Related]
9. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M
J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
Berneis K; Ninnis R; Girard J; Frey BM; Keller U
J Clin Endocrinol Metab; 1997 Aug; 82(8):2528-34. PubMed ID: 9253329
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
Tally M; Eriksson U; Thorén M; Brismar K; Hall K
J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
[TBL] [Abstract][Full Text] [Related]
13. Effects of low dose of recombinant human growth hormone on renal excretion of insulin-like growth factor-I (IGF-I) in humans: an inverse relation between serum and urinary IGF-I level.
Uemasu J; Fujihara M; Kawasaki H
Clin Nephrol; 1996 Jul; 46(1):1-5. PubMed ID: 8832140
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans.
Oehri M; Ninnis R; Girard J; Frey FJ; Keller U
Am J Physiol; 1996 Apr; 270(4 Pt 1):E552-8. PubMed ID: 8928758
[TBL] [Abstract][Full Text] [Related]
16. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO
J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
[TBL] [Abstract][Full Text] [Related]
17. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
Pascual M; Larralde J; Martínez JA
Growth Dev Aging; 1995; 59(4):181-91. PubMed ID: 8770610
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects.
Guler HP; Schmid C; Zapf J; Froesch ER
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2868-72. PubMed ID: 2649897
[TBL] [Abstract][Full Text] [Related]
19. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
Mauras N; Horber FF; Haymond MW
J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
[TBL] [Abstract][Full Text] [Related]
20. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
